Clinical Trial Update: Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide [Phase 2]

View source ↗

Summary

Phase 2 trial investigating arsenic trioxide for treatment of chronic graft-versus-host disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Medsenic | Conditions: Chronic Graft-Versus-Host Disease, Immune System Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-05-09